PackTalk is a blog for the Healthcare Packaging Industry

Eli Lilly Starts Human Study of Potential COVID-19 Antibody Test


Published on June 4, 2020

Companies and research institutions around the world are racing to find a viable treatment for COVID-19, which has already caused ~370,000 deaths worldwide and continues to rise. Eli Lilly recently announced their progress, and are moving into the human study portion of their antibody treatment. They have developed this treatment from a blood sample that was taken from one of the first patients in the United States to have recovered from the lung illness caused by COVID-19. 

Eli Lilly is anticipating results to their study by end of June. Read more about the treatment here.


Comments (0)

Related Articles

1 Simple Question that Will Drive Your IVD Packaging

May 14, 2021

The In Vitro Diagnostics (IVD) industry is fascinating, and as precision medicine is prioritized more heavily around the world, it is important that we understand the industry from even the most basic level. When I was talking with a colleague recently about...

Learn More

Two Nurses Explain the Difference Between OR and ER Packaging

May 14, 2021

We know how valuable it is to gain insight from nurses; they are the core end-users of sterile healthcare packaging. Have you ever considered the myriad environments, procedures, and medical devices they manage, or how this vast diversity impacts a nurse’s...

Learn More

The Next Decade of Medical Packaging Belongs to China – Part 2

May 14, 2021

Part two of our three-part series examines how China’s evolving medical device market helped the country during the pandemic. It also looks back at what changes took place as the healthcare sector found itself at center stage of the world’s COVID-19 response. 

Learn More

Stay Informed

To stay up to date on innovative technology and products, as well as industry trends, subscribe to Oliver’s PackTalk blog below.